首页 >
法规速递
-
Document: Overview of comments received on the “HMA/EMA guidance document on the identification of personal data and commercially confidential information within the structure of the marketing authorisation application (MAA) dossier” - public consultation
2025-07-31查看详情 > -
Page: Aprepitant product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Vortioxetine hydrobromide / vortioxetine lactate product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Zonisamide product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: List of medicinal products under additional monitoring-2025/7/30
2025-07-31查看详情 > -
Document: List of medicinal products under additional monitoring-2025/7/30
2025-07-31查看详情 > -
Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2025/7/30
2025-07-31查看详情 > -
Page: Paclitaxel product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Emtricitabine/tenofovir disoproxil product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Colchicine product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 >
